Results 211 to 220 of about 156,077 (286)

Contemporary Approaches to Opioid Dependence Treatment Delivery: A Rapid Review of Novel Models Relevant to Implementation in Victoria, Australia

open access: yesDrug and Alcohol Review, Volume 45, Issue 6, September 2026.
ABSTRACT Issues Rising opioid‐related harms and persistent barriers to opioid dependence treatment (ODT) access present critical challenges across Australia and internationally. Pharmacotherapy remains the most effective treatment for opioid use disorder, yet systemic gaps in workforce availability and service models limit reach and sustainability ...
Shalini Arunogiri   +4 more
wiley   +1 more source

Long‐Acting Injectable Buprenorphine in Prison: Insights From a Short‐Answer Survey of People in the Criminal Justice System Commencing Long‐Acting Injectable Buprenorphine During a Non‐Randomised Clinical Trial

open access: yesDrug and Alcohol Review, Volume 45, Issue 6, September 2026.
ABSTRACT Introduction Long‐acting injectable buprenorphine (LAIB) is increasingly used in the Criminal Justice System (CJS) for treating people with opioid use disorder; however, little is known about these patients' experiences. We aimed to understand the perspectives of participants commenced on LAIB in prison as a part of the Understanding NSW Long ...
Amelia Woods   +8 more
wiley   +1 more source

Opioid overdose associated with concomitant use of hydrocodone and selective serotonin reuptake inhibitors. [PDF]

open access: yesBMC Med
Bea S   +6 more
europepmc   +1 more source

Advancing Spectroscopy‐Based Drug Checking Training: A Proof‐of‐Concept Study for the Use of Concordance Analysis

open access: yesDrug and Alcohol Review, Volume 45, Issue 6, September 2026.
ABSTRACT Introduction Drug checking is a harm reduction strategy that provides information to people who use drugs. Currently, there is a lack of standardised, replicable methods to assess drug checking technicians' use of spectroscopy‐based technologies.
Yarelix Estrada   +5 more
wiley   +1 more source

Patient and Provider Demand for and Readiness to Adopt Medications for Stimulant Use Disorders in Real‐World Settings: Pre‐Planning Toward Accelerated Implementation

open access: yesDrug and Alcohol Review, Volume 45, Issue 6, September 2026.
ABSTRACT Introduction In the United States, rates of stimulant use disorder (StUD) have increased over the last 20 years, yet fewer than one‐third of adults receive treatment. Recent research has shown the efficacy of medication for StUD, but little is known regarding demand and readiness to adopt such treatments.
Enya B. Vroom   +4 more
wiley   +1 more source

Identifying novel gene dysregulation associated with opioid overdose death: a meta-analysis of differential gene expression in human prefrontal cortex. [PDF]

open access: yesTransl Psychiatry
Carter JK   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy